National Cancer Survivors Day

Screen Shot 2015-06-04 at 11.40.30 AM

This Sunday, June 7th, is National Cancer Survivors Day.  It is a CELEBRATION for those who have survived, an INSPIRATION for those recently diagnosed, a gathering of SUPPORT for families, and an OUTREACH to the community.  

We hope that everyone who has been touched by cancer is able to connect with others to celebrate those who have survived and support those who are grieving.  This day brings attention to not only the need for further research and funding to treat and cure cancer but also to the specific issues faced by the growing population of cancer survivors worldwide.



People Magazine Highlights Fertility Preservation

Screen Shot 2015-05-13 at 8.59.35 AM

Screen Shot 2015-05-13 at 9.00.44 AMOn May 12th, People Magazine highlighted a story about a 16 year old Arizona teen, McKindree Patton, who elected to freeze her eggs prior to chemotherapy for a rare form of bone marrow failure.  Through the help of non-profit group Angel Mamas, McKindree was provided funds to cover the fertility preservation procedures.  And when a friend of hers was diagnosed recently with the same rare bone marrow failure, McKindree helped navigate her through the necessariy fertility preservation steps to treatment.  Read more about McKindree’s story.






NPC Member Spotlight: Main Line Fertility

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to  If you are interested in learning more about how to join the NPC, contact Brigid Smith at or (312)503-2506.



In 2012 Main Line Fertility Center joined the Oncofertility Consortium at Northwestern University and launched an official Fertility Preservation Program. This program was created to educate recently diagnosed cancer patients about their options and to increase access to fertility preservation procedures during the small window of opportunity between diagnosis and treatment.

We offer egg, sperm and embryo freezing prior to chemotherapy or other medical/surgical treatments. We are available 24 hours a day via email: All patients will be given an appointment with one of our physicians within 24 hours of initial contact. Patients are assigned a Nurse Coordinator who will walk them through the process every step of the way. Drs. Glassner and Orris have greatly reduced the usual cost of IVF and in conjunction with select pharmaceutical companies are able to provide Oncofertility patients free fertility medications.

Patients are treated with the utmost care as we facilitate their fertility preservation treatment assuring that their cancer treatment is not delayed.  Our team is committed to being there for our patients “every step of the way”.

Females desiring Egg or Embryo Freezing:

Call Anne Wendel, Oncofertility Coordinator, at 484.380.4879 or email

At the initial appointment patients will be seen by one of the Main Line Fertility physicians, have bloods drawn, and meet with IVF nurses to discuss an IVF cycle from start to finish. Patient’s partners will also require blood work and semen analysis, if applicable.

Please bring photo ID and insurance cards.

Males desiring Sperm Freezing:

Call the Andrology Lab for an appointment: 484.380.4863. Identify yourself as an oncology patient and ask to speak with laboratory staff.

Specimens are routinely collected at the Center Monday through Friday prior to 12:00 noon. Weekend hours are available on an emergency basis.

Bring an andrology request form or prescription with your doctor’s signature to your collection appointment.

Photo ID is required. If the patient is a minor, the legal guardian must accompany the patient.

Ideally, the sperm specimen should be collected at the clinic in one of our private collection rooms. However, arrangements can be made for off-site collection if circumstances warrant.

Meet our Team

MichaelGlassner2013-121x155Michael J. Glassner, MD

Dr. Glassner is a founding partner and the medical director at Main Line Fertility and Reproductive Medicine. He also is a clinical professor at Drexel School of Medicine and clinical educator at Jefferson Medical School. He is also the founding Director of the Center for Reproductive Medicine at Bryn Mawr Hospital and under his tutelage has become a leading IVF center in the area.


JohnOrris2014-121x155John J. Orris, DO, MBA

Dr. John Orris is a partner at Main Line Fertility and Reproductive Medicine, and he is the Division Head of Reproductive Endocrinology and Infertility for Main Line Health System. Dr. Orris is an Associate Professor at the Drexel University College of Medicine, and he is Fellowship Director for Reproductive Endocrinology and Infertility for Drexel University College of Medicine and Main Line Fertility. He joined Main Line Fertility in July 2003 and has focused his time and efforts serving patients in the western suburbs of Philadelphia.

deanna-121x155Deanna Brasile, DO

Dr. Deanna Brasile joined Main Line Fertility in October 2012, and she sees patients in our West Chester and Paoli offices. She joined us with over eight years of experience in the infertility field.

Dr. Brasile grew up in Erie, Pennsylvania. She received her undergraduate degree in psychology at Duke University. She completed medical school at the Philadelphia College of Osteopathic Medicine and also did an internship there. Her residency and training in obstetrics and gynecology was completed at the Robert Wood Johnson School of Medicine in Camden/ Cooper University Medical Center.

SharonAnderson2014Sharon H. Anderson, PhD, ELD, HCLD

Dr. Anderson is the Laboratory Director and Scientific Director Main Line Fertility Center. She directs the embryology, IVF, andrology, and endocrinology laboratories. She is an adjunct Associate Professor in the Department of OB/GYN at Drexel University School of Medicine, and she serves on the Research Committee. In addition, Dr. Anderson is responsible for marketing and strategic planning for the practice. She received her Bachelor of Science and Master of Science degrees in Animal Bioscience from Pennsylvania State University. Her research focused on the interaction between gametes/embryos and the oviduct. Subsequently, she received her Ph.D. in Physiology from Penn State University. While completing a post-doctoral scholarship in microbiology, she also taught Human Physiology at Juniata College.

Phone: (484) 380-4884, email:

AnneAnne Wendel, RN, BSN

Anne joined Main Line Fertility Center in 1998. She is the Clinical Director and Oncofertility Coordinator.

Phone: 484.380.4879, email:


Support the Oncofertility Consortium!

Screen Shot 2015-05-07 at 3.23.38 PM

On May 31st, the Oncofertility Consortium will participate in the Lurie Cancer Center’s 22nd Annual Cancer Survivors’ Celebration Walk & 5K in Chicago, Illinois.  Our goals are to celebrate those who have survived, to inspire those recently diagnosed and to promote cancer awareness in our community.

All money raised through the Oncofertility Consortium team will support the ground breaking research done within our lab at Northwestern University as well as facilitate initiatives across our National Physicians Cooperative and Global Partnerships.  These funds will help us continue to investigate ways to mitigate the effects of any disease or treatment on ovarian and testicular function and develop physician-guided tools that will allow for communication and translation between basic research and clinical practice.

Please consider making a gift to our team or walking with us: 

NPC Member Spotlight: Children’s Hospital of Philadelphia

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to  If you are interested in learning more about how to join the NPC, contact Brigid Smith at or (312)503-2506.



The core goals of the Fertility Preservation Program at The Children’s Hospital of Philadelphia (CHOP) focus on clinical service, education (family and provider) and research. Goals include:

  • Providing a clinical consultation service for health care providers as well as direct counseling for patients at risk for infertility due to their medical condition and/or its treatment
  • Facilitating timely referrals for fertility preservation methods considered standard clinical care (sperm banking, oocyte/embryo freezing, ovarian transposition)
  • Offering cutting edge, experimental options for fertility preservation (testicular and ovarian tissue cryopreservation) within the context of organized research protocols
  • Working with laboratory experts to expand and refine the current scientific knowledge needed to transform the state of reproductive medicine in this area

In January 2009, Fertile Hope named CHOP as a Center of Excellence for its commitment to inform all cancer patients and their families of the infertility risk of cancer treatment and to offer potential ways to preserve fertility. We are the first children’s hospital to achieve this distinction and we continue to provide leadership in the area of fertility preservation, both nationally and abroad.

We are pleased to be able to offer fertility preservation options to both prepubertal and pubertal males and females.


  • Sperm Banking
  • Testicular Tissue Cryopreservation (via participation in a research protocol)


  • Oocyte Freezing
  • Embryo Freezing
  • Ovarian Transposition
  • Ovarian Tissue Cryopreservation (via participation in a research protocol)


Jill P. Ginsberg, MD, is a pediatric oncologist and director of the Cancer Survivorship Program at CHOP’s Cancer Center. She is also the director of CHOP’s Fertility Preservation Program.

Thomas F. Kolon, MD, is an attending pediatric urologist at The Children’s Hospital of Philadelphia. He provides surgical expertise for our testicular tissue procedures.

Peter Mattei, MD, FACS, FAAP, is an attending pediatric surgeon at The Children’s Hospital of Philadelphia. He provides surgical expertise for our ovarian tissue procedures.

Clarisa R. Gracia, MD, MSCE, Director, Fertility Preservation, Associate Professor of Obstetrics and Gynecology, Hospital of the University of Pennsylvania. Dr. Gracia is a leading fertility preservation expert and provides counseling, oocyte retrieval/cryopreservation, and surgical services for our female patients.

Christine Hill-Kayser, MD is the chief of the Pediatric Service for the Department of Radiation Oncology at the Hospital of the University of Pennsylvania.

Michael J. Glassner, MD, Director at Main Line Fertility and Reproductive Medicine. Dr. Glassner is our local partner for sperm banking as well as oocyte/embryo freezing.

Sue Ogle, RN, MSN, CRNP

Wendy Hobbie, RN, MSN, CRNP, FAAN

Claire A. Carlson, BSN, RN, Nurse Coordinator

Maureen Prewitt, BA, BSN, RNC, Director of Clinical Research Support, Oncofertility, Women’s Health Clinical Research Center, Penn Fertility Care


Ralph L. Brinster, V.M.D., Ph.D. , Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.

Sandra W. Ryeom, Ph.D. , Assistant Professor of Cancer Biology, University of Pennsylvania



This Is Awkward: A resource for boys considering sperm banking

Fertility Options for Young Female Cancer Patients



If you have questions or would like to discuss coming to CHOP for fertility preservation, feel free to contact Claire Carlson at 215-590-0432.



NPC Member Spotlight: Michigan Reproductive Medicine

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to  If you are interested in learning more about how to join the NPC, contact Brigid Smith at or (312)503-2506.




Michigan Reproductive Medicine has been freezing eggs since 2008 and is the first fertility center in Michigan to successfully freeze eggs and have babies born from frozen eggs.

Our center is committed to providing patients with the most up-to date technology. Fertility preservation by egg freezing is a true game-changer by providing women the greatest opportunity to control their reproductive futures.

Fertility Preservation Services Offered

An egg or embryo freezing cycle requires quick decision-making and communication between the patient, the woman’s oncologist and Dr. Mersol-Barg. Working together as a team and educating the patient about her cancer therapy’s impact on her fertility empowers the patient to make the best decision regarding her fertility preservation.

We provide the following services to women:

Embryo Freezing 







Egg Freezing 







Contact Information

Please call Michigan Reproductive Medicine at (248) 593-6990 or visit our website at to find out more about your fertility preservation options.

Michigan Reproductive Medicine

41000 Woodward Ave., Suite 100 East

Bloomfield Hills, MI 48304

Phone: 248-593-6990

Fax: 248-593-5925




Michael S. Mersol-Barg, MD, Director, Michigan Reproductive Medicine






NPC Member Spotlight: Ann and Robert H. Lurie Children’s Hospital of Chicago

We’re exited to continue our new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to  If you are interested in learning more about how to join the NPC, contact Brigid Smith at or (312)503-2506.


Screen Shot 2015-04-21 at 8.58.49 AM

Today, improved treatments of cancer and other diseases give patients the hope of long term survival. However, many of the treatments that increase survival may cause loss of fertility. New technologies in reproductive medicine are providing possibilities for preserving fertility.

Lurie Children’s is dedicated to working with families, patients and healthcare providers to guide them in deciding if fertility preservation is appropriate for their child.

As a member of the National Physicians Cooperative of the Oncofertility Consortium, Lurie Children’s Fertility Preservation Program offers services to pediatric, adolescent and young adult patients. This consortium of fertility experts, oncologists, surgeons, urologists, endocrinologists and researchers are working together to provide fertility preservation options to patients who are seeking to preserve fertility due to cancer treatment, surgery, or a congenital condition.

Fertility preservation options

We have a comprehensive range of services for pre- and post-pubertal patients. These include:

For Males

Testis shielding

Sperm cryopreservation

Testicular sperm extraction (TESE)

Testicular tissue freezing (experimental)

For Females

Ovarian shielding

Oophoropexy/ovarian transposition

Oocyte or embryo freezing

Ovarian tissue freezing (experimental)

Gonadotropin analogues (experimental)

The treatment team will work with you to determine the best options to suit your needs.

Each patient is unique, so fertility preservation must be tailored and carefully integrated with a patient’s treatment. Appropriate fertility preservation options depend on the age of the patient, as well as the treatment the patient is to receive. If treatment has been completed and there is a concern about the patient’s ability to have children, families are encouraged to seek a consultation with a fertility expert.

For more information or to schedule an appointment, please contact:

Barbara Lockart, DNP, APN/CNP, CPON, at Lurie Children’s at


Multidisciplinary team of specialists

Our multidisciplinary team works together to ensure that every patient receives the best fertility preservation care available. This team consists of:


Yasmin Gosiengfiao, MD

Attending Physician, Hematology/Oncology/Stem Cell Transplant; Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Barbara Lockart, DNP, APN/CNP, CPON

Pediatric Nurse Practitioner in Hematology/Oncology/Stem Cell Transplant; Patient Navigator for Fertility Preservation, Lurie Children’s Hospital

Pediatric Surgery

Marleta Reynolds, MD

Head, Pediatric Surgery; Professor of Surgery, Northwestern University Feinberg School of Medicine

Erin Rowell, MD

Attending Physician, Pediatric Surgery; Assistant Professor of Surgery, Northwestern University Feinberg School of Medicine


Wendy Brickman, MD

Attending Physician, Endocrinology; Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Courtney Finlayson, MD

Attending Physician, Endocrinology; Instructor in Pediatrics, Northwestern University Feinberg School of Medicine

Jill Samis, MD

Attending Physician, Endocrinology, Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Reema Habiby, MD

Attending Physician, Endocrinology; Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine


Earl Cheng, MD

Division Head, Urology; Professor of Urology, Northwestern University Feinberg School of Medicine

Robert Brannigan, MD

Attending Physician, Urology,Northwestern Medicine; Professor of Surgery, Northwestern University Feinberg School of Medicine

Emilie Johnson, MD, MPH

Attending Physician, Urology; Assistant Professor of Urology, Northwestern University Feinberg School of Medicine

Elizabeth Yerkes, MD

Attending Physician, Urology; Associate Professor of Urology, Northwestern University Feinberg School of Medicine

Valerie Gillis, MMS, PA-C

Physician Assistant, Urology; Northwestern Medicine

Obstetrics and Gynecology/Reproductive Endocrinology and Infertility

Mary Ellen Pavone, MD,

Attending Physician, Reproductive Endocrinology and Infertility; Assistant Professor of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine

Kristin Smith

Patient Navigator for Fertility Preservation, Northwestern Medicine/Robert H. Lurie Comprehensive Cancer Center 


Teresa Woodruff, PhD

Thomas J Watkins Professor of Obstetrics and Gynecology at the Feinberg School of Medicine; Chief of the Division of Fertility Preservation and Oncofertility Consortium


Find us on Social Media

Screen Shot 2015-03-31 at 9.50.53 AM

Did you know that the Oncofertility Consortium is accessible on multiple social media platforms?  You can find us on: Twitter, Facebook, Pinterest, YouTube as well as the blog!

Follow us, friend us, tweet us – we want to connect with all of you!

If you have news or events you wish to have highlighted, you can contact us directly through these social media accounts or email us at


Kevin J. Lederer Life Foundation

Screen Shot 2015-03-31 at 11.00.37 AM

The Oncofertility Consortium is excited to announce a new opportunity for Illinois individuals and couples struggling with infertility and its associated costs.  The Kevin J. Lederer Life Foundation is a 501c3 that will provide educational programs as well as financial assistance.  

The Foundation is not tied to any specific fertility group and grants are awarded on the financial and need-based determination of the medical board.  Grants can be used towards infertility treatment at any Illinois practice or towards the cost of adoption.  The Life grant application is now open and applications must be received by July 30, 2015.


Clinical Referrals: Cancer Knowledge Network

We welcome our Canadian Global Partners, Cancer Knowledge Network, as guests today on our blog.  Read on below for information about their program.



Fertility Clinic Referral for Breast Cancer Patients: The Sooner the Better

by Dr. Ellen Warner, MD, M.Sc., FRCPC, FACP

Contrary to long-held myths, we now know from well-designed studies that:

  1. Newly diagnosed breast cancer patients don’t just care about surviving breast cancer.  They also want to have normal lives once their treatment is over and retaining the ability to get pregnant is at the top of their agenda.  This is more of an issue now than it was several decades ago because, since women today tend to delay childbearing, many young breast cancer patients haven’t even started let alone completed their families.
  1. Getting pregnant after a breast cancer diagnosis, whether it ends in miscarriage or a healthy live birth, is safe even for patients with hormone sensitive (ER+) tumors.

This is excellent news for our young breast cancer patients.  But things are not so simple.  Chemotherapy damages the ovaries and probably shortens a woman’s natural fertility span by 5 to 10 years.   Tamoxifen, which is often prescribed for at least 5 years, doesn’t damage the ovaries but it does cause fetal malformations so women must not get pregnant while taking the drug. Since fertility drops with age, delaying pregnancy to take several years of tamoxifen means a greater risk of infertility.

Fortunately, there are now excellent fertility preservation options for women who need chemotherapy and/or tamoxifen but want to maximize their chance of having one or more babies in the future.   Women in stable relationships can have embryos (fertilized eggs) frozen while single women can freeze unfertilized eggs.  While both procedures require a brief period of hormonal stimulation to enable the harvesting of multiple eggs, studies to date show no evidence of an increase in cancer recurrence rates.  Fertility preservation takes several weeks, must be completed before chemotherapy or tamoxifen is started and may require difficult personal and financial decisions for some women.  Consequently, the earlier a woman is referred to a fertility specialist (ideally right after her breast cancer diagnosis), the more time she’ll have to make these decisions and the less likely it is that her cancer treatment will have to be delayed.

Discussion of fertility issues with all newly diagnosed breast cancer patients of reproductive age and early referral to a fertility clinic, if appropriate, has been strongly recommended by the American Society of Clinical Oncology.  Unfortunately, however, the majority of young breast cancer patients are not getting the opportunity to have fertility preservation.  Barriers include lack of information for oncologists and patients, and lack of access to fertility clinics.

In Canada, the new CKN Oncofertility Referral Network is a most welcome solution to these issues.  From our experience at our cancer centre with PYNK: Breast Cancer Program for Young Women, we have discovered that by disseminating fertility information to oncologists and patients, and with close co-operation between oncologists and fertility specialists, we can ensure that every patient (for whom fertility preservation is appropriate) receives a timely referral to a fertility clinic.  Thanks to the CKN Oncofertility Referral Network, young breast cancer patients across Canada will have the same opportunity.

Dr. Warner is a medical oncologist and Professor of Medicine at the University of Toronto who has been at the Odette Cancer Centre since 1993, where her practice and research have been devoted to breast cancer.  In 1994, she created a program for hereditary breast and ovarian cancer patients, which introduced genetic counseling and testing to the Odette Cancer Centre. Related research includes the determination of mutation prevalence in patient subgroups, gene-environment interactions and the development of validated educational materials for patients and physicians. Since 1997, she has led a study to explore the role of magnetic resonance imaging (MRI) in screening women with an inherited predisposition to develop breast cancer which has helped make annual MRI surveillance the standard of care for this very high risk population. Over the last few years she has created PYNK: Breast Cancer Program for Young Women, an interdisciplinary clinical and research program for young breast cancer patients which was officially launched in 2008. This program, the only one of its kind in Canada, addresses the unique tumour biology as well as the special medical and psychosocial needs of this population.

Page 2 of 5812345...102030...Last »
© Oncofertility Consortium Blog